A critical review of aspirin in the secondary prevention of noncardioembolic ischaemic stroke

International Journal of Stroke : Official Journal of the International Stroke Society
Domenico InzitariCristina Sarti

Abstract

Both secondary prevention (such as lifestyle modifications, pharmacotherapy or surgery) and an understanding of the influence of risk factors (including the different aetiologic mechanisms of cerebral ischaemia) play a pivotal role in reducing the burden of recurrent stroke. Regarding the types of preventative treatments available, variations exist across all clinical studies, including differences in target populations (including the type of cerebral ischaemia), risk factors, length of follow-up, drop-out rates and outcomes, which makes translating the results of clinical trials to individual patients difficult. However, with such limitations in mind, this critical albeit nonsystematic review, which compared aspirin with other antiplatelets and in combination with other drugs, showed that the benefit from aspirin treatment is consistently shown in ischaemic stroke, while harms are limited. Furthermore, no definite superiority is apparent across different antiplatelet therapies. Dual antiplatelet regimens may expose to a slight but measurable higher risk of haemorrhagic complications, perhaps in selective groups of patients (i.e. those with severe small-vessel disease or in selective racial groups). Based on our analysis, the i...Continue Reading

References

May 1, 1977·Stroke; a Journal of Cerebral Circulation·W S FieldsR J Hardy
Jul 13, 1978·The New England Journal of Medicine·UNKNOWN Canadian Cooperative Study Group
Oct 1, 1988·Stroke; a Journal of Cerebral Circulation·G BoysenP Joensen
Oct 2, 1971·Lancet·M J HarrisonR W Russell
Feb 1, 1994·Stroke; a Journal of Cerebral Circulation·J BurnC Warlow
Feb 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·A Algra, J van Gijn
Apr 21, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·A AlgraP J Koudstaal
Jan 5, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·N Delanty
Nov 29, 2001·American Journal of Epidemiology·C AyalaJ S Marks
Jan 10, 2002·Stroke; a Journal of Cerebral Circulation·Moira K KapralJack V Tu
Jan 17, 2002·The New England Journal of Medicine·J P MohrUNKNOWN Warfarin-Aspirin Recurrent Stroke Study Group
Jun 12, 2003·JAMA : the Journal of the American Medical Association·Philip B GorelickUNKNOWN African American Antiplatelet Stroke Prevention Study Investigators
Jun 28, 2003·Stroke; a Journal of Cerebral Circulation·U G R Schulz, P M Rothwell
Apr 14, 2004·Neurology·A CulebrasUNKNOWN TAPIRSS investigators
Apr 17, 2004·Stroke; a Journal of Cerebral Circulation·V L SerebruanyJ J Ferguson
Apr 28, 2004·Neurology·Philip B Gorelick
Jan 8, 2005·Stroke; a Journal of Cerebral Circulation·James P StansburyPamela W Duncan
Mar 12, 2005·Journal of the Neurological Sciences·Laszlo K SztrihaLaszlo Vecsei
Apr 1, 2005·The New England Journal of Medicine·Marc I ChimowitzUNKNOWN Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators
Jun 18, 2005·Stroke; a Journal of Cerebral Circulation·Dawn M BravataJohn Concato
Jan 13, 2006·British Journal of Pharmacology·Gustav Born, Carlo Patrono
Jan 25, 2006·Circulation·Scott E KasnerUNKNOWN Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators
Feb 21, 2006·Lancet·Graeme J Hankey, John W Eikelboom
Mar 15, 2006·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHARISMA Investigators
Aug 26, 2006·Stroke; a Journal of Cerebral Circulation·Tetsuya OhiraAaron R Folsom

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylating

Software Mentioned

PRoFESS
TACIP
ESPS2
ESPRIT

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.